STARBOARD ULTRA 86L: 2025 TEST REVIEW THE VERDICT Providing some comfort when powered, the Ultra looks for a proactive rider who can provide and drive (…) ...

He also shared a version of the presentation his hedge fund Starboard presented to Pfizer officials at a meeting last week. "It's not often that investors and shareholders are able to see what we ...

85 LITRE ALL-ROUND WAVE BOARD TEST 2025: WAVE MACHINES After getting their hands on a selection of the latest and greatest 85L wave sleds, our Test (…) ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights.

Among them, and two terms that you definitely need to understand, are port and starboard. You probably know that one means “left” and one means “right,” but which is which and why do ...

According to Starboard, Pfizer’s expected revenue return on R&D and M&A investments is projected at 15% between 2023 and 2030, far below the industry median of 38%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. This data feed is not available at this time.

Oct 20 (Reuters) - Hedge fund Starboard Value has taken a stake in Kenvue (KVUE.N), opens new tab, the consumer products company that makes Band-Aid, Listerine, and Tylenol, and which went public ...

At an investor summit in New York on Tuesday, activist investor Starboard called out Pfizer's PFE board of directors to take action against the latter’s management for making poor capital ...

Activist investor Starboard Value has taken a sizeable stake in Kenvue Inc., the maker of Tylenol and Listerine, and is ...

Activist investor Starboard Value has amassed a sizeable stake in Kenvue Inc. (NYSE:KVUE), the consumer-products company that makes Tylenol and Listerine. The exact size of Starboard's stake in ...